Mapping how B cells recognize different antigens
Technologies for High-Throughput Mapping of Antigen Specificity to B-Cell-Receptor Sequence
This study is looking at how a type of immune cell called B cells identifies and reacts to different germs and substances, which could help create better treatments for conditions like cancer and autoimmune diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11066480 on NIH RePORTER |
What this research studies
This research focuses on understanding how B cells, a crucial part of the immune system, recognize and respond to various antigens, which are substances that trigger an immune response. By developing advanced technologies, the project aims to link the genetic sequences of B cell receptors to their specific antigen targets. This approach will allow for a more comprehensive understanding of antibody functions and improve the discovery of new antibodies for diagnostics and therapies. Patients may benefit from enhanced treatments for diseases like cancer, autoimmune disorders, and infections as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with autoimmune diseases, cancers, or other conditions where B cell responses are critical.
Not a fit: Patients with conditions unrelated to B cell function or those who do not have an active immune response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective antibody-based therapies and diagnostics for a range of diseases.
How similar studies have performed: Previous research has shown promise in linking antibody sequences to their functions, but this specific approach is innovative and aims to overcome existing limitations.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Georgiev, Ivelin — Vanderbilt University Medical Center
- Study coordinator: Georgiev, Ivelin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.